1346112-79-5
1346112-79-5
Chemical Structure
Thromboxane B2-d4
- CAS No.: 1346112-79-5
- Formula:C20H30D4O6
- Molecular Weight:374.51
IUPAC Name: (Z)-7-((2R,3S,4S,6R)-4,6-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)tetrahydro-2H-pyran-3-yl)hept-5-enoic-3,3,4,4-d4 acid
InChIKey: XNRNNGPBEPRNAR-AZDPWLPUSA-N
SMILES: O=C(O)CC([2H])([2H])C([2H])([2H])/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H](O)C[C@@H]1O
Biological Activity: Thromboxane B2-D4 is the deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Thromboxane B2-d4 | 99.9% | Thromboxane B2-D4 is the deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Thromboxane B2-d9 | Thromboxane B2-d9 is deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Thromboxane B2 | 99.0% | Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation. Thromboxane B2 is a biological inactive product and circulating catabolite of thromboxane A2. Thromboxane B2 levels in peripheral venous blood and coronary sinus blood can be used as a diagnostic marker for angina. Thromboxane B2 level in serum is also associated with inhibition of COX-1 activity inhibition in platelets. Thromboxane B2 is a major product of prostaglandin endoperoxide metabolism. Thromboxane B2 produces dose-related decreases in airflow rate, tidal volume and dynamic lung compliance, whilst simultaneously increasing pulmonary airway resistance in dog model. Thromboxane B2 appears to be a naturally occurring bronchoactive metabolite in the bioconversion of arachidonic acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
